FERRING PHARMACEUTICALS PRIVATE LIMITED

<p><strong>4.1 Therapeutic indications</strong><br> MENOPUR&reg; is indicated for the treatment of infertility in the following clinical situations:</p> <p>Anovulation, including polycystic ovarian disease (PCOD), in women who have been unresponsive to treatment with clomiphene citrate.</p> <p>Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART) (e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI).</p> <p>Sterility in females with hypo- or normogonadotropic ovarian insufficiency: Stimulation of follicular growth.</p>

**4.1 Therapeutic indications** MENOPUR® is indicated for the treatment of infertility in the following clinical situations: Anovulation, including polycystic ovarian disease (PCOD), in women who have been unresponsive to treatment with clomiphene citrate. Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART) (e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI). Sterility in females with hypo- or normogonadotropic ovarian insufficiency: Stimulation of follicular growth.

**THERAPEUTIC INDICATIONS** NOCDURNA® is indicated for symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults (see section Pharmacodynamic properties – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).

**THERAPEUTIC INDICATIONS** NOCDURNA® is indicated for symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults (see section Pharmacodynamic properties – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).

**THERAPEUTIC INDICATIONS** ENDOMETRIN® is indicated for luteal support as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.

**THERAPEUTIC INDICATIONS** Treatment of mild to moderate ulcerative colitis.

<p><strong>4.1 Therapeutic Indications</strong><br> MENOPUR&reg; is indicated for the treatment of infertility in the following clinical situations:</p> <p>Anovulation, including polycystic ovarian disease (PCOD), in women who have been unresponsive to treatment with clomiphene citrate.</p> <p>Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART) (e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)).</p> <p>Sterility in females with hypo- or normogonadotropic ovarian insufficiency: Stimulation of follicular growth.</p>

**THERAPEUTIC INDICATIONS** ZOMACTON® is indicated for: - the long-term treatment of children who have growth failure due to inadequate secretion of growth hormone. - the long-term treatment of growth retardation due to Turner’s Syndrome confirmed by chromosome analysis.

<p><strong>THERAPEUTIC INDICATIONS</strong><br> FIRMAGON&reg; is a gonadotrophin releasing hormone (GnRH) antagonist indicated for treatment of adult male patients with advanced hormone-dependent prostate cancer.</p>

**Therapeutic indications** MINIRIN® oral lyophilisate is indicated for the treatment of central diabetes insipidus. MINIRIN® oral lyophilisate is indicated for the treatment of primary nocturnal enuresis in patients (from 5 years of age) with normal ability to concentrate urine.